You are here Home Safety and shortages Safety monitoring and information Safety alerts Safety review of diclofenac Version 2.1, October 2014 Published 28 February 2014 Last updated 7 October 2014 Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Following the cardiovascular safety review of all NSAIDs and concerns regarding the risk of hepatotoxicity, the Office of Product Review (OPR) conducted a full safety review of diclofenac. Supporting documents Safety review of diclofenac [PDF, 681.65 KB] Safety review of diclofenac [DOCX, 269.87 KB] Product types Prescription medicines Page history Show all page updates (3) 7 October 2014 V2.1Minor editorial changes 29 August 2014 V2.0Revision following comments from sponsors 28 February 2014 V1.0Original report 7 October 2014 V2.1Minor editorial changes 29 August 2014 V2.0Revision following comments from sponsors 28 February 2014 V1.0Original report
